Navigation Links
PWeR(TM) Introduced at Regional Healthcare Conference
Date:2/3/2009

ed on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective company's Securities and Exchange Commission 10-KSB, 10-QSB, S-8, SB-2, S-1 and 8-K filings (and amendments thereto) that may cause actual results to materially differ from projections. Forward-looking statements can be identified by the use of words such as "expects," "plans," "will," "may," "anticipates," "believes," "should," "intends," "estimates" "could" and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by these forward-looking statements. Such risk factors include, without limitation, the ability of the Company to properly execute its business model, to raise substantial and immediate additional capital to implement its business model, to continue revenue growth trend in fiscal year 2009, to control patient medical cost relative to income received, to attract and retain executive, management and operational personnel, to continue growing its patient base, to negotiate favorable current debt and future capital raises, to negotiate favorable agreements with a diversified provider base and to continue to supply the services needed by its HMO clients as well as physician clients. We have further risk in the deployment of our technology platform, the utilization by our clients, technical and software setbacks, cost of development, as well as the capital to deploy it. We are subject further to interruptions of service. Company does not undertake any obligation to publicly update any forward-looking statements. As a result, investors should not place undue reliance on these forward-looking statements.

                    FOR MORE INFORMATI
'/>"/>
SOURCE The Quantum Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. The Quantum Group Announces Exclusive Screening of New PWeR(TM) System
2. PWeR(TM) Platform Available to Increase Provider Reimbursements From Medicare
3. National CPR/AED Awareness Week Introduced in Congress
4. New Nutraceutical That Stabilizes Blood Sugar Naturally is Introduced
5. New Ovarian Cancer Biomarker Research Act Introduced
6. Chicken pox vaccination should be introduced for children in the UK
7. Arizona Patient Protection Act Introduced
8. "Campus Alert by VoiceGate" introduced at Internet Telephony(R) Conference and Expo
9. Groundbreaking Sign Chi Do Stress Management System Introduced by Dr. Anne Borik Now Available to the Public
10. Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment
11. New Stretch Mark and Skin Rejuvenation Treatment Introduced to Houston by Dr. Zaniewski-Singh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Brook, New York (PRWEB) May 22, 2013 ... that specializes in combining treatments for optimal results, is ... thin skin on the neck. The practice has ... seen dramatic results. , “Basically, this approach is for ... lift,” says Westchester dermatologist Dr. Michelle Abadir ...
(Date:5/22/2013)... of the antidepressant Lexapro appears to help prevent ... study finds. The condition is known ... people with this condition may not develop noticeable ... blood supply, according to researchers from Duke University ... the researchers found that people taking the antidepressant ...
(Date:5/22/2013)... research from Brigham and Women,s Hospital (BWH) finds that ... but deadly lung disease, may be effective in identifying ... will be presented at the American Thoracic Society International ... England Journal of Medicine on May 22 and ... "While this variant of the MUC5B gene is fairly ...
(Date:5/22/2013)... May 22, 2013 The PreDiabetes Center ... participation in the Greater Philadelphia Tour de Cure, a premier ... who are passionate about stopping the spread of diabetes ... Americans. , The Tour de Cure will take place ... Meetinghouse Road in Ambler, 30 minutes outside of Philadelphia, between ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Following the ... fitness franchise Fit Body Boot Camp Kincardine ... 1,000 lb. Meltdown Challenge starting on June 3rd at ... Centre 601 Durham Street, Kincardine, Ontario.     , Fit Body ... inspire and motivate local community residents to lose a ...
Breaking Medicine News(10 mins):Health News:Westchester Dermatologist Abadir Associates Offers New Neck Lift Surgery Alternative 2Health News:Antidepressants May Be Helpful for Some Heart Patients: Study 2Health News:Antidepressants May Be Helpful for Some Heart Patients: Study 3Health News:Genetic marker associated with risk for pulmonary fibrosis 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 3Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3
... Favorite, and ,Have Fun Helping It ... ... Recession? Killer bees? No! Only positive predictions, please.,That,s the attitude of Richard ... debut last month., *(PHOTO 72dpi: Send2Press.com/mediaboom/07-1115-DSamson_72dpi.jpg), *(Photo Caption: SuperLife founder ...
... /Xinhua-PRNewswire-FirstCall/ -- China Sky One,Medical, Inc. (OTC Bullion ... medicinal and diagnostic products in China,today announced that ... Company,s Form 10QSB for the fiscal quarters ended ... filed its full year 2006 amendments on,November 8, ...
... 18 Escalon Medical Corp.,(Nasdaq Capital Market: ESMC) ... clearance from the U.S. Food and Drug,Administration (FDA) ... differential Hematology Analyzer. Drew Scientific plans to,commence shipments ... month-end., "The FDA clearance represents a major ...
... PHILADELPHIA A new brain imaging study by researchers ... Pennsylvania shows that cigarette cravings in smokers who are ... specific regions of the brain. Using a novel method ... MD, associate professor of Neurology at Penn, this study ...
... (NYSE: CDI ),announced today that the Life ... been awarded a contract from CJ CheilJedang,Corporation to ... manufacturing complex to be located in Osong, Korea. ... center for global,distribution of oral solid and sterile ...
... where he worked as a ... ... Dikembe,Mutombo, who is known as much for his philanthropy as his storied ... organization prepare its entry into his home country, the,Democratic Republic of Congo ...
Cached Medicine News:Health News:Six Positive Predictions for 2008, from SuperLife World Service 2Health News:China Sky One Medical Completes Previously Announced Amendments to Form 10QSB for the Second and Third Quarters of 2006 2Health News:Escalon(R) Announces FDA 510(K) Clearance for D3 Hematology System 2Health News:Escalon(R) Announces FDA 510(K) Clearance for D3 Hematology System 3Health News:New neuroimaging study identifies 'brain signature' for cigarette cravings 2Health News:CDI-Life Sciences Selected by CJ CheilJedang Corp. to Provide Engineering Design for Major Pharmaceutical Complex in Korea 2Health News:NBA Legend Dikembe Mutombo Joins Opportunity International Board of Advisors; Opens Doors in Democratic Republic of Congo 2Health News:NBA Legend Dikembe Mutombo Joins Opportunity International Board of Advisors; Opens Doors in Democratic Republic of Congo 3Health News:NBA Legend Dikembe Mutombo Joins Opportunity International Board of Advisors; Opens Doors in Democratic Republic of Congo 4
(Date:5/22/2013)... LEWIS CENTER, Ohio , May 22, 2013 ... of Opioid Defense Manager™ (ODM).  Launched in November ... Medical,s revolutionary managed care program to stop the ... ODM is a proactive, customized program designed to ... drug use while maintaining the necessary balance to ...
(Date:5/22/2013)... -- Z-Medica, a leading developer and marketer of hemostatic ... of products designed to meet the unique needs of ... EMS 4x4 Dressing, QuikClot ® EMS TraumaPad ® ... custom-designed to help responders stop bleeding fast and keep ... hospital or trauma center. The line includes products designed ...
(Date:5/22/2013)... MAPLE GROVE, Minn. , May 22, ... today announced the successful completion of its ... (extended-release topiramate), an internally developed program for ... the company,s proprietary formulation technology.  USL255 is ... and reduce fluctuations in topiramate blood levels ...
Breaking Medicine Technology:Modern Medical Introduces Opioid Abuse Solution to the Workers' Compensation Industry 2Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4
... SAN DIEGO, Feb. 18, 2011 Zimmer Holdings, Inc. (NYSE: ... care, today announced it has received FDA clearance for the ... TM-S system is the industry,s first cervical interbody device incorporating ... device for cervical interbody fusion (IBF) in the United ...
... Bellicum Pharmaceuticals, Inc. today announced the presentation ... BPX-101, a novel drug-activated dendritic cell vaccine for ... separate posters at the 2011 Genitourinary Cancers Symposium ... 19, 2011. Three leading medical specialty societies co-sponsor ...
Cached Medicine Technology:Zimmer Spine Introduces Industry's First Porous Metal Cervical Interbody Device 2Zimmer Spine Introduces Industry's First Porous Metal Cervical Interbody Device 3Clinical Responses Demonstrated in Metastatic Castrate Resistant Prostate Cancer Patients Treated With BPX-101 Cancer Vaccine 2Clinical Responses Demonstrated in Metastatic Castrate Resistant Prostate Cancer Patients Treated With BPX-101 Cancer Vaccine 3
... the hand, the Jarvik 2000 pump is about ... welded titanium shell sits a direct-current motor, a ... single moving part: a small, spinning titanium impeller ... to 7 liters per minute. Rather than take ...
... cardiac assist system primarily designed as a permanent ... failure., ,It is a blood pump that connects ... to help the ailing hearts pumping function and ... , ,It can also be used as a ...
... The Masimo SET LNOP Blue Sensor is ... babies. The LNOP Blue sensor is ... accuracy claims for cyanotic infants and children. ... presented challenging conditions for reliable and accurate ...
... The Trinity Biotech Captia™ Varicella-Zoster Virus (VZV) ... for the detection and quantitative determination of ... Individual serum specimens may be used for ... acute and convalescent, may be used to ...
Medicine Products: